Kamada (KMDA) Capital Expenditures (2013 - 2026)

Kamada (KMDA) posted quarterly Capital Expenditures of -$973000.0 for Q1 2026, up 33.72% year-on-year from -$727643.4 in Q1 2025, and down 138.57% on a QoQ basis from $2.5 million in Q4 2025.

Kamada (KMDA) Capital Expenditures (2013 - 2026) Analysis & Trends

Kamada (KMDA) has reported Capital Expenditures for 14 consecutive years, with -$973000.0 the latest figure, recorded in Q1 2026.

  • Quarterly Capital Expenditures rose 33.72% year-over-year to -$973000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.1 million (up 12.78% YoY) and the FY2025 annual result came in at -$9.8 million, down 603.63% from the prior year.
  • Capital Expenditures eased to -$973000.0 in Q1 2026 per KMDA's latest filing, from $2.5 million in the prior quarter.
  • Over the last five years, Capital Expenditures for KMDA reached as high as $2.5 million in Q4 2025 and fell as low as -$3.6 million in Q3 2025.
  • A 5-year average of -$836043.1 and a median of -$977000.0 in 2022 frame the typical range for Capital Expenditures.
  • The largest YoY upside for Capital Expenditures was 202.63% in 2024 against a maximum downside of 240007.43% in 2024.
  • Year by year, Capital Expenditures stood at -$977000.0 in 2022, then jumped by 166.12% to $646000.0 in 2023, then surged by 202.63% to $2.0 million in 2024, then grew by 29.05% to $2.5 million in 2025, then slumped by 138.57% to -$973000.0 in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods registered -$973000.0, $2.5 million, and -$3.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 168.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 110.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.95 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 99.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 39.90 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 51.00 Mn
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn -973,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -973,000.00
Mar 31, 2026 -973,000.00
Dec 31, 2025 2.52 Mn
Dec 31, 2025 2.52 Mn
Sep 30, 2025 -3.59 Mn
Sep 30, 2025 -3.59 Mn
Jun 30, 2025 -2.01 Mn
Jun 30, 2025 -2.01 Mn
Mar 31, 2025 -1.47 Mn
Mar 31, 2025 -1.47 Mn
Dec 31, 2024 1.96 Mn
Dec 31, 2024 1.96 Mn
Sep 30, 2024 -2.12 Mn
Sep 30, 2024 -2.12 Mn
Jun 30, 2024 -3.01 Mn
Jun 30, 2024 -3.01 Mn
Mar 31, 2024 -2.68 Mn
Mar 31, 2024 -2.68 Mn
Dec 31, 2023 646,000.00
Dec 31, 2023 646,000.00